Tag: antibody therapy

FDA, Regulations

FDA Authorizes Lilly COVID-19 Antibody Combination for Emergency Use

February 10, 2021

Via: Genetic Engineering and Biotechnology News

The FDA last night granted Emergency Use Authorization (EUA) for a 700 mg dose of bamlanivimab (LY-CoV555) in combination with a 1400 mg dose of a second Lilly antibody candidate, etesevimab (LY-CoV016), for the treatment of mild to moderate COVID-19 […]